End-Stage Liver Disease in a State Prison Population

Annals of Epidemiology

Volumn 17, Issue 10, 2007, Pages 808-813

  Baillargeon, Jacques ^a   Soloway, Roger D ^a   Paar, David ^a   Giordano, Thomas P ^a   Murray, Owen ^a   Grady, James ^a   Williams, Brie ^a   Pulvino, John ^a   Raimer, Ben G ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

End Stage Liver Disease; Hepatitis C; HIV; Prisons

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE; HEALTH PROGRAM; HEPATITIS C; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PRISONER; UNITED STATES;

ADULT; COHORT STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PRISONERS; TEXAS;

EID: 34548589094     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2007.04.005     Document Type: Article

References (38)

1. Baillargeon J., Black S.A., Leach C.T., et al. The infectious disease profile of Texas prison inmates. Prev Med 38 (2004) 604-612
2. Baillargeon J., Wu H., Kelley M.J., Grady J., Linthicum L., and Dunn K. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health 117 (2003) 43-48
3. De Groot A.S., Stubblefield E., and Bick J. Hepatitis C: a correctional-public health opportunity. Medscape Infect Dis 3 (2001) 1-11
4. Wu Z.H., Baillargeon J., Grady J.J., Black S.A., and Dunn K. HIV seroprevalence among newly incarcerated inmates in the Texas correctional system. Ann Epidemiol 11 (2001) 342-346
5. Hammett T.M., Harmon M.P., and Rhodes W. The burden of infectious disease among inmates of and releases from US correctional facilities, 1997. Am J Public Health 92 (2002) 1789-1794
6. Ruiz JD, Mikanda J. (Department of Health Services). Seroprevalence of HIV, hepatitis B, hepatitis C, and risk behaviors among inmates entering the California correctional system. 1996.
7. Spaulding A., Greene C., Davidson K., Schneidermann M., and Rich J. Hepatitis C in state correctional facilities. Prev Med 29 (1999) 92-100
8. Vlahov D., Nelson K.E., Quinn T.C., and Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol 9 (1993) 566-569
9. Macalino G.E., Vlahov D., Sanford-Colby S., et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health 94 (2004) 1218-1223
10. Weinbaum C.M., Sabin K.M., and Santibanez S.S. Hepatitis, B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS 19 Suppl 3 (2005) S41-S46
11. Alter M.J., Kruszon-Moran D., Nainan O.V., et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341 (1999) 556-562
12. Spaulding A., Stephenson B., Macalino G.E., Ruby W., Clarke J.G., and Flanigan T.P. Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis 35 (2002) 305-312
13. Massard J., Ratziu V., Thabut D., et al. Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol 44 Suppl 1 (2006) S19-S24
14. Mumola CJ. (U.S. Department of Justice). Medical causes of death in state prisons, 2001-2004. 2007.
15. Boutwell A., and Rich J.D. HIV infection behind bars. Clin Infect Dis 38 (2004) 1761-1763
16. Wright J. Medically necessary organ transplants for prisoners: who is responsible for payment?. Boston Coll Law Rev 39 (1998) 1251-1292
17. Trotter J.F., and Osgood M.J. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes. JAMA 291 (2004) 1871-1874
18. Bell B.P., Navarro V.J., Manos M.M., et al. The epidemiology of newly-diagnosed chronic liver disease in the United States: findings of population-based sentinel surveillance. [abstract]. Hepatology 34 (2001) 468A
19. Cox DH. (Department of Health and Human Services). Chronic liver disease and cirrhosis deaths in California. 2006.
20. Bica I., McGovern B., Dhar R., et al. Increasing mortality due to end stage liver disease in patients with human immunodeficiency virus infection. HIV Outpatient Study Investigators. Clin Infect Dis 34 (2001) 831-837
21. Soto B., Sanchez-Quijano A., Rodrigo L., et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 26 (1997) 1-5
22. Benhamou Y., Bochet M., Di Martino V., et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30 (1999) 1054-1058
23. Telfer P.T., Brown D., Devereaux H., Lee C.A., and DuSheiko G.M. HCV RNA levels and HIV infection: evidence for viral interaction in haemophilic patients. Br J Haepatology 88 (1994) 397-399
24. Martin P., Di Bisceglie A.M., Kassianides C., Lisker-Melman M., and Hoofnagle J.H. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 97 (1989) 1559-1561
25. Poynard T., Ratziu V., Charlotte F., Goodman Z., McHutchinson J., and Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 34 (2001) 730-739
26. Deuffic-Burban S., Poynard T., and Valleron A.J. Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model. J Viral Hepat 9 (2002) 114-122
27. Seef L.B. Natural history of hepatitis C. Hepatology 26 (1997) 21S-28S
28. Maddow R, Bick J., The management of end stage liver disease in the correctional setting. 2003.
29. Spaulding A., Weinbaum C.M., Lau D.T., Sterling R., and Seef L.B. A framework for management of hepatitis C in prisons. Ann Intern Med 144 (2006) 762-769
30. Ortner NJ. (Milliman Consultants and Actuaries). 2005 U.S. Organ and Tissue Transplant Cost Estimates and Discussion. 2005.
31. Strader D.B., Wright T., Thomas D.L., and Seeff L.B. Diagnosis, management, and treatment of hepatitis C. Hepatology 39 (2004) 1147-1171
32. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the advisory committee on the immunization practices (ACIP). MMWR Recomm Rep 48 1 (1999)
33. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment and guidelines. MMWR Recomm Rep 51 1 (2002)
34. Okie S. Sex, drugs, prisons, and HIV. N Engl J Med 356 (2007) 105-108
35. West J.C., Kelley S.E., Schwartz J.A., Bertsch D.J., and Marsh J.F. Organ allocation: a case for not transplanting the violent criminal. Semin Dial 16 (2003) 362-364
36. Fireman M., and Metcalf M. Ethics for financing transplantation for inmates of jails and prisons. Curr Opinion Organ Transplant 7 (2002) 380-384
37. Kahn J. The ethics of organ transplantation for prisoners. Semin Dial 16 (2003) 365-366
38. Meyers C. A new liver for a prisoner. Hastings Cent Rep 32 4 (2002) 12-13